Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount USFD Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment CBAN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Beat Driven by Investment Portfolio Stock Remains Flat PRU Q1 2026 Earnings Earnings Beat Estimates by 154 Amid Solid Insurance Performance